Table 1.

Application of guidelines for reporting preclinical in vitro studies on dental materials for the selected studies in the systematic review (n = 17).

First Author, Year	Item N° *
	1	2	3	4	5	6	7	8	9	10	11	12	13	14
Senawongse, 2007 [29]	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	Yes	Yes	No	Yes	No
Ergucu, 2008 [30]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No	No
Ozel, 2008 [31]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No
Scheibe, 2009 [32]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No	No
Atabek, 2010 [33]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	No
da Silva, 2010 [34]	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	No	Yes	Yes	No	Yes	No
Janus, 2010 [35]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No
Antonson, 2011 [36]	No	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	Yes	Yes	No
Berger, 2011 [37]	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	No	Yes	Yes	Yes	Yes	No
Buchgraber, 2011 [38]	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	No	Yes	Yes	No	Yes	No
Erdemir, 2012 [3]	Yes	No	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	Yes	No	No
Nunes, 2013 [39]	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	Yes	Yes	No	No	No
Avsar, 2015 [40]	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	Yes	Yes	No	No	No
Aytac, 2016 [41]	Yes	Yes	Yes	Yes	Yes	No	No	Yes	Yes	Yes	Yes	No	Yes	No
Yadav, 2016 [20]	No	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No	No
de Carvalho Justo Fernandes, 2016 [42]	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No
Alfawaz, 2017 [43]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No	No

* Item 1: summary; Item 2: Introduction, background and objectives; Item 3: methods, intervention; Item 4: results; Item 5: sample size; Item 6: randomization, generation of sequences; Item 7: allocation concealment mechanism; Item 8: implementation; Item 9: blinding; Item 10: statistical methods; Item 11: results and estimation; Item 12: discussion, limitations; Item 13: other information, financing; Item 14: protocol.